Skip to main navigation Skip to content
  • Contact Us
Site Logo
  • About Us
    • Locations
    • Leadership Team
    • Board of Directors
    • ABL Bio
  • Our Expertise
    • Technology
    • EpyQ® Production System
    • Platform Innovation
    • Gene Therapy Formulation
    • Scalable Manufacturing
    • Process Development
    • Aseptic Fill-Finish
    • Analytics & GMP QC Testing
      • Viral Vector Long‑Read NGS
      • Potency Assay Services
  • News & Insights
    • News
    • Articles
    • Blogs
    • Webinar
  • Events
  • Resources
    • Posters
    • White Papers
    • Additional Resources
  • Careers
  • Contact Us

15 May 2025

Gaining control of rAAV production: real-time monitoring with Raman Spectroscopy

Read More

15 May 2025

High yield & full-empty ratios achieved with a scalable GMP-ready AEX chromatography

Read More

15 May 2025

Extraction-free ddPCR quantification of host-cell derived E1A impurities in rAAV samples

Read More

15 May 2025

ABL’s HIV p24 ELISA Kit: a Solution for Lentivirus Quantification in Industrial Processes

Read More

5 May 2025

Solving the AAV Scalability Challenge

Read More

5 May 2025

Considerations for AAV Analytical Comparability Studies for Products with Low Batch Numbers

Read More

2 May 2025

Gene Therapy Process Development Support to Optimize AAV Yield & Quality from Gene to GMP Production

Read More

2 May 2025

Gene Therapy Formulation

Read More

2 May 2025

Analytics-driven AAV Development & Manufacturing

Read More

2 May 2025

ABL Viral Vector Manufacturing Experts

Read More

2 May 2025

ABL Drug Product Fill/Finish Services

Read More

21 January 2025

Recombinant AAV batch profiling by nanopore sequencing elucidates product-related DNA impurities and vector genome length distribution

Read More
< Back 1 2 3 4 … 6 Next >
Site Logo

9800 Medical Center Drive • Building D
Rockville, MD 20850 USA

Linkedin
  • Terms and Conditions
  • Privacy Policy
  • Cookie Policy

© 2026 Ascend Advanced Therapies Ltd. All Rights Reserved.